Selective Peroxisome Proliferator-Activated Receptor-γ Modulation in the Treatment of Hypertension and Metabolic Syndrome: The Role of Angiotensin II Receptor Blockers

Author： Borghi Claudio  

Publisher： Adis International

ISSN： 1120-9879

Source： High Blood Pressure & Cardiovascular Prevention, Vol.13, Iss.3, 2006-01, pp. : 81-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Peroxisome Proliferator-Activated Receptor-γ Modulation to Reduce Cardiovascular Risk in Patients with Insulin Resistance

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 1, 2012-04 ,pp. : 33-41

Bentham Science Publishers

Access to resources Recommend Favorite

Partial Peroxisome Proliferator-Activated Receptor Agonist Angiotensin Receptor Blockers

By  

Cerebrovascular Diseases, Vol. 26, Iss. 2, 2008-06 ,pp. : 106-112

Karger

Access to resources Recommend Favorite

Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ gene in women with polycystic ovary syndrome

By Yilmaz Murat   Ali Ergün Mehmet   Karakoç Ayhan   Yurtçu Erkan   Çakir Nuri   Arslan Metin  

Gynecological Endocrinology, Vol. 22, Iss. 6, 2006-06 ,pp. : 336-342

Informa Healthcare

Access to resources Recommend Favorite

Dual Peroxisome Proliferator-Activated Receptor-α/ Agonists: In the Treatment of Type 2 Diabetes Mellitus and the Metabolic Syndrome

By Pershadsingh Harrihar A.  

Treatments in Endocrinology, Vol. 5, Iss. 2, 2006-01 ,pp. : 89-99

Adis International

Access to resources Recommend Favorite

Peroxisome Proliferator Activated Receptor-γ (PPAR-γ) Ligands and Angiogenesis

By Margeli A.   Kouraklis G.   Theocharis S.  

Angiogenesis, Vol. 6, Iss. 3, 2003-01 ,pp. : 165-169

Springer Publishing Company

Access to resources Recommend Favorite